SCHEMBL5459772

SCHEMBL5459772

Cc1nc(N)nc2c1C(=O)CC(c1ccccc1OC1CCCC1)C2

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 8/20 0.60
HSP90AB1 P08238 7/20 0.60
RXFP1 Q9HBX9 1/20 0.40
HPGD P15428 3/20 0.39
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.37
TRAP1 Q12931 1/20 0.36
TP53 P04637 1/20 0.36
MCHR1 Q99705 2/20 0.36
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
MAP1LC3B Q9GZQ8 1/20 0.34
P2RX3 P56373 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14582290 0.99 HSP90AA1 (0.58) HSP90AA1HSP90AB1RXFP1HPGDALDH1A1
SCHEMBL5462346 0.88 HSP90AA1 (0.50) HSP90AA1HSP90AB1HPGDTRAP1TP53
SCHEMBL1779006 0.85 HSP90AA1 (0.66) HSP90AA1HSP90AB1HPGDALDH1A1SMN1; SMN2
SCHEMBL5464922 0.85 HSP90AA1 (0.54) HSP90AA1HSP90AB1HPGDALDH1A1SMN1; SMN2
SCHEMBL4620975 0.84 HSP90AA1 (0.67) HSP90AA1HSP90AB1RXFP1HPGDALDH1A1
SCHEMBL4618817 0.83 HSP90AA1 (0.60) HSP90AA1HSP90AB1RXFP1HPGDALDH1A1
SCHEMBL5471332 0.83 HSP90AA1 (0.62) HSP90AA1HSP90AB1HPGDALDH1A1SMN1; SMN2
SCHEMBL5463191 0.83 HSP90AA1 (0.62) HSP90AA1HSP90AB1HPGDALDH1A1SMN1; SMN2
SCHEMBL5470543 0.83 HSP90AA1 (0.62) HSP90AA1HSP90AB1HPGDALDH1A1SMN1; SMN2
SCHEMBL4620866 0.83 HSP90AA1 (0.65) HSP90AA1HSP90AB1HPGDALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027150-A1 2-Amino-quinazolin-5-ones TK1, TK2, SLC1A5 HSP90AA1 3373/4885HSP90AB1 3036/4885RXFP1 3855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.